Burleson & Co’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Burleson & Co’s Portfolio MDVL Stock Details MDVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$330	Sell	22 -2	-8%	-$58	﹤0.01%	389
2022 Q3	$1K	Hold	24	–	–	﹤0.01%	387
2022 Q2	$2K	Hold	24	–	–	﹤0.01%	354
2022 Q1	$1K	Hold	24	–	–	﹤0.01%	394
2021 Q4	$2K	Sell	24 -22	-48%	-$2.37K	﹤0.01%	321
2021 Q3	$7K	Hold	46	–	–	﹤0.01%	277
2021 Q2	$28K	Hold	46	–	–	﹤0.01%	224
2021 Q1	$32K	Buy	+46	New	+$33.1K	0.01%	208

Other funds holding MDVL

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Cigna Investments Bloomfield, Connecticut $773M AUM 44.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Burleson & Co's MDVL Position: Q4 2022 in Review

Burleson & Co reduced its MedAvail Holdings, Inc. Common Stock (MDVL) stake by 8.3% in Q4 2022, selling an estimated $58 and leaving 22 shares worth $330. The position accounts for ﹤0.01% of the portfolio, ranked #389.

Burleson & Co first reported a position in MDVL in Q1 2021 and has held it in 8 quarters since. The position peaked at $32K in Q1 2021. 30 funds tracked by Wall St. Rank hold MDVL as of Q4 2022.

Burleson & Co held 22 shares of MedAvail Holdings, Inc. Common Stock worth $330 as of Q4 2022.
Burleson & Co sold 2 MedAvail Holdings, Inc. Common Stock shares in Q4 2022, an estimated $58.
MedAvail Holdings, Inc. Common Stock made up ﹤0.01% of Burleson & Co's portfolio in Q4 2022, its #389 holding.
Burleson & Co first reported a position in MedAvail Holdings, Inc. Common Stock in Q1 2021 and has held it in 8 quarters since.
Burleson & Co's MedAvail Holdings, Inc. Common Stock position peaked at $32K in Q1 2021.
30 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.